Annual Cash & Cash Equivalents
$8.46 M
-$10.63 M-55.68%
May 26, 2024
Summary
- As of February 12, 2025, LFCR annual cash & cash equivalents is $8.46 million, with the most recent change of -$10.63 million (-55.68%) on May 26, 2024.
- During the last 3 years, LFCR annual cash & cash equivalents has risen by +$7.30 million (+630.11%).
- LFCR annual cash & cash equivalents is now -86.47% below its all-time high of $62.56 million, reached on May 1, 2007.
Performance
LFCR Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$9.46 M
+$3.94 M+71.29%
November 24, 2024
Summary
- As of February 12, 2025, LFCR quarterly cash and cash equivalents is $9.46 million, with the most recent change of +$3.94 million (+71.29%) on November 24, 2024.
- Over the past year, LFCR quarterly cash and cash equivalents has increased by +$6.38 million (+207.68%).
- LFCR quarterly cash and cash equivalents is now -84.89% below its all-time high of $62.56 million, reached on May 1, 2007.
Performance
LFCR Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LFCR Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -55.7% | +207.7% |
| 3 y3 years | +630.1% | +207.7% |
| 5 y5 years | +683.5% | +493.2% |
LFCR Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -55.7% | +753.9% | -50.5% | +854.1% |
| 5 y | 5-year | -55.7% | +2250.6% | -50.5% | +2526.4% |
| alltime | all time | -86.5% | +2250.6% | -84.9% | +2526.4% |
Lifecore Biomedical Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Nov 2024 | - | $9.46 M(+71.3%) |
| Aug 2024 | - | $5.52 M(-34.8%) |
| May 2024 | $8.46 M(-55.7%) | $8.46 M(+175.4%) |
| Feb 2024 | - | $3.07 M(-4.6%) |
| Nov 2023 | - | $3.22 M(-62.7%) |
| Aug 2023 | - | $8.64 M(-54.7%) |
| May 2023 | $19.09 M(+1826.4%) | $19.09 M(+547.2%) |
| Feb 2023 | - | $2.95 M(-56.8%) |
| Nov 2022 | - | $6.83 M(+61.8%) |
| Aug 2022 | - | $4.22 M(+326.0%) |
| May 2022 | $991.00 K(-14.5%) | $991.00 K(-46.5%) |
| Feb 2022 | - | $1.85 M(+69.9%) |
| Nov 2021 | - | $1.09 M(-24.6%) |
| Aug 2021 | - | $1.45 M(+24.8%) |
| May 2021 | $1.16 M(+221.9%) | - |
| May 2021 | - | $1.16 M(-48.4%) |
| Feb 2021 | - | $2.25 M(-9.8%) |
| Nov 2020 | - | $2.49 M(+322.9%) |
| Aug 2020 | - | $589.00 K(+63.6%) |
| May 2020 | $360.00 K(-66.7%) | $360.00 K(-86.2%) |
| Feb 2020 | - | $2.61 M(+63.6%) |
| Nov 2019 | - | $1.59 M(-19.9%) |
| Aug 2019 | - | $1.99 M(+84.3%) |
| May 2019 | $1.08 M(-62.7%) | $1.08 M(-37.3%) |
| Feb 2019 | - | $1.72 M(+13.7%) |
| Nov 2018 | - | $1.51 M(+11.4%) |
| Aug 2018 | - | $1.36 M(-53.1%) |
| May 2018 | $2.90 M(-51.7%) | $2.90 M(-62.1%) |
| Feb 2018 | - | $7.65 M(+75.1%) |
| Nov 2017 | - | $4.37 M(-46.7%) |
| Aug 2017 | - | $8.19 M(+36.6%) |
| May 2017 | $6.00 M(-39.4%) | $6.00 M(-52.9%) |
| Feb 2017 | - | $12.73 M(+396.3%) |
| Nov 2016 | - | $2.57 M(-70.3%) |
| Aug 2016 | - | $8.63 M(-12.8%) |
| May 2016 | $9.89 M(-30.0%) | $9.89 M(+20.5%) |
| Feb 2016 | - | $8.21 M(+37.5%) |
| Nov 2015 | - | $5.97 M(-15.9%) |
| Aug 2015 | - | $7.10 M(-49.7%) |
| May 2015 | $14.13 M(-0.8%) | $14.13 M(-10.0%) |
| Feb 2015 | - | $15.70 M(+215.8%) |
| Nov 2014 | - | $4.97 M(-41.7%) |
| Aug 2014 | - | $8.53 M(-40.1%) |
| May 2014 | $14.24 M(+3.8%) | $14.24 M(+9.7%) |
| Feb 2014 | - | $12.99 M(+125.2%) |
| Nov 2013 | - | $5.77 M(-35.2%) |
| Aug 2013 | - | $8.90 M(-35.1%) |
| May 2013 | $13.72 M(-38.1%) | $13.72 M(+38.0%) |
| Feb 2013 | - | $9.94 M(+104.8%) |
| Nov 2012 | - | $4.86 M(-51.7%) |
| Aug 2012 | - | $10.05 M(-54.7%) |
| May 2012 | $22.18 M(+172.6%) | $22.18 M(+76.9%) |
| Feb 2012 | - | $12.53 M(+196.0%) |
| Nov 2011 | - | $4.24 M(-41.5%) |
| Aug 2011 | - | $7.24 M(-11.0%) |
| May 2011 | $8.13 M | $8.13 M(+21.8%) |
| Feb 2011 | - | $6.68 M(+22.6%) |
| Nov 2010 | - | $5.45 M(-45.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Aug 2010 | - | $9.90 M(-64.4%) |
| May 2010 | $27.82 M(-36.0%) | $27.82 M(+338.8%) |
| Feb 2010 | - | $6.34 M(+185.3%) |
| Nov 2009 | - | $2.22 M(-44.4%) |
| Aug 2009 | - | $4.00 M(-90.8%) |
| May 2009 | $43.46 M(-2.1%) | $43.46 M(-8.1%) |
| Feb 2009 | - | $47.28 M(+11.6%) |
| Nov 2008 | - | $42.34 M(-7.4%) |
| Aug 2008 | - | $45.75 M(+3.0%) |
| May 2008 | $44.40 M(-29.0%) | $44.40 M(-19.7%) |
| Feb 2008 | - | $55.27 M(+22.5%) |
| Nov 2007 | - | $45.13 M(-2.4%) |
| Aug 2007 | - | $46.25 M(-26.1%) |
| May 2007 | $62.56 M(+312.5%) | $62.56 M(+7.3%) |
| Feb 2007 | - | $58.30 M(+396.1%) |
| Nov 2006 | - | $11.75 M(-18.2%) |
| Aug 2006 | - | $14.36 M(-5.3%) |
| May 2006 | $15.16 M(+17.8%) | $15.16 M(-24.5%) |
| Feb 2006 | - | $20.09 M(+211.5%) |
| Nov 2005 | - | $6.45 M(-23.4%) |
| Aug 2005 | - | $8.42 M(-34.6%) |
| May 2005 | $12.87 M(+99.3%) | $12.87 M(-13.6%) |
| Feb 2005 | - | $14.90 M(+139.7%) |
| Nov 2004 | - | $6.21 M(+11.3%) |
| Aug 2004 | - | $5.58 M(-13.5%) |
| May 2004 | $6.46 M(+74.6%) | $6.46 M(+3.4%) |
| Feb 2004 | - | $6.25 M(+172.1%) |
| Nov 2003 | - | $2.30 M(-47.5%) |
| Aug 2003 | - | $4.37 M(+22.7%) |
| May 2003 | $3.70 M(-52.9%) | - |
| Apr 2003 | - | $3.56 M(-33.3%) |
| Jan 2003 | - | $5.34 M(-32.0%) |
| Oct 2002 | $7.85 M(-9.7%) | $7.85 M(+543.9%) |
| Jul 2002 | - | $1.22 M(-85.8%) |
| Apr 2002 | - | $8.60 M(+13.1%) |
| Jan 2002 | - | $7.60 M(-12.6%) |
| Oct 2001 | $8.70 M(+0.7%) | $8.70 M(+59.4%) |
| Jul 2001 | - | $5.46 M(-8.1%) |
| Apr 2001 | - | $5.94 M(-8.8%) |
| Jan 2001 | - | $6.51 M(-24.6%) |
| Oct 2000 | $8.64 M(+169.9%) | $8.64 M(-20.6%) |
| Jul 2000 | - | $10.88 M(+68.6%) |
| Apr 2000 | - | $6.45 M(-23.2%) |
| Jan 2000 | - | $8.40 M(+162.5%) |
| Oct 1999 | $3.20 M(-65.2%) | $3.20 M(-25.6%) |
| Jul 1999 | - | $4.30 M(-42.7%) |
| Apr 1999 | - | $7.50 M(-16.7%) |
| Jan 1999 | - | $9.00 M(-2.2%) |
| Oct 1998 | $9.20 M(+76.9%) | $9.20 M(+53.3%) |
| Jul 1998 | - | $6.00 M(-45.0%) |
| Apr 1998 | - | $10.90 M(-5.2%) |
| Jan 1998 | - | $11.50 M(+121.2%) |
| Oct 1997 | $5.20 M(-63.4%) | $5.20 M(-32.5%) |
| Jul 1997 | - | $7.70 M(+285.0%) |
| Apr 1997 | - | $2.00 M(-80.8%) |
| Jan 1997 | - | $10.40 M(-26.8%) |
| Oct 1996 | $14.20 M | $14.20 M(+4.4%) |
| Jul 1996 | - | $13.60 M(-32.7%) |
| Apr 1996 | - | $20.20 M |
FAQ
- What is Lifecore Biomedical annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Lifecore Biomedical?
- What is Lifecore Biomedical annual cash & cash equivalents year-on-year change?
- What is Lifecore Biomedical quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Lifecore Biomedical?
- What is Lifecore Biomedical quarterly cash and cash equivalents year-on-year change?
What is Lifecore Biomedical annual cash & cash equivalents?
The current annual cash & cash equivalents of LFCR is $8.46 M
What is the all time high annual cash & cash equivalents for Lifecore Biomedical?
Lifecore Biomedical all-time high annual cash & cash equivalents is $62.56 M
What is Lifecore Biomedical annual cash & cash equivalents year-on-year change?
Over the past year, LFCR annual cash & cash equivalents has changed by -$10.63 M (-55.68%)
What is Lifecore Biomedical quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LFCR is $9.46 M
What is the all time high quarterly cash and cash equivalents for Lifecore Biomedical?
Lifecore Biomedical all-time high quarterly cash and cash equivalents is $62.56 M
What is Lifecore Biomedical quarterly cash and cash equivalents year-on-year change?
Over the past year, LFCR quarterly cash and cash equivalents has changed by +$6.38 M (+207.68%)